1. Home
  2. AZTA vs IOVA Comparison

AZTA vs IOVA Comparison

Compare AZTA & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • IOVA
  • Stock Information
  • Founded
  • AZTA 1978
  • IOVA 2007
  • Country
  • AZTA United States
  • IOVA United States
  • Employees
  • AZTA N/A
  • IOVA N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AZTA Technology
  • IOVA Health Care
  • Exchange
  • AZTA Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • AZTA 2.4B
  • IOVA 2.6B
  • IPO Year
  • AZTA 1995
  • IOVA N/A
  • Fundamental
  • Price
  • AZTA $52.63
  • IOVA $5.91
  • Analyst Decision
  • AZTA Buy
  • IOVA Strong Buy
  • Analyst Count
  • AZTA 5
  • IOVA 9
  • Target Price
  • AZTA $61.60
  • IOVA $23.33
  • AVG Volume (30 Days)
  • AZTA 595.5K
  • IOVA 9.1M
  • Earning Date
  • AZTA 02-05-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • AZTA N/A
  • IOVA N/A
  • EPS Growth
  • AZTA N/A
  • IOVA N/A
  • EPS
  • AZTA N/A
  • IOVA N/A
  • Revenue
  • AZTA $656,323,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • AZTA N/A
  • IOVA $13,758.71
  • Revenue Next Year
  • AZTA $6.32
  • IOVA $171.20
  • P/E Ratio
  • AZTA N/A
  • IOVA N/A
  • Revenue Growth
  • AZTA N/A
  • IOVA 12751.20
  • 52 Week Low
  • AZTA $38.82
  • IOVA $5.62
  • 52 Week High
  • AZTA $69.16
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 64.67
  • IOVA 28.87
  • Support Level
  • AZTA $50.79
  • IOVA $5.62
  • Resistance Level
  • AZTA $53.47
  • IOVA $6.44
  • Average True Range (ATR)
  • AZTA 1.78
  • IOVA 0.45
  • MACD
  • AZTA 0.01
  • IOVA -0.10
  • Stochastic Oscillator
  • AZTA 75.83
  • IOVA 11.46

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: